Global and China Geriatric Medicine Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 22-Sep-2021
No. of pages: 109
Inquire Before Buying

Global Geriatric Medicine Scope and Market Size

Geriatric Medicine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Geriatric Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Analgesics

- Antihypertensives

- Statins

- Antidiabetics

- Proton Pump Inhibitor

- Anticoagulant

- Antipsychotic

- Antidepressant

Segment by Application

- Cardiovascular

- Arthritis

- Neurological

- Cancer

- Osteoporosis

- Respiratory

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- GSK

- Boehringer Ingelheim

- Novartis

- Bristol-Myers Squibb

- Pfizer

- Eli Lilly

- Abbott

- AstraZeneca

- Merck

- Sanofi S.A.

Global and China Geriatric Medicine Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Geriatric Medicine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Analgesics
1.2.3 Antihypertensives
1.2.4 Statins
1.2.5 Antidiabetics
1.2.6 Proton Pump Inhibitor
1.2.7 Anticoagulant
1.2.8 Antipsychotic
1.2.9 Antidepressant
1.3 Market by Application
1.3.1 Global Geriatric Medicine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cardiovascular
1.3.3 Arthritis
1.3.4 Neurological
1.3.5 Cancer
1.3.6 Osteoporosis
1.3.7 Respiratory
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Geriatric Medicine Market Perspective (2016-2027)
2.2 Geriatric Medicine Growth Trends by Regions
2.2.1 Geriatric Medicine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Geriatric Medicine Historic Market Share by Regions (2016-2021)
2.2.3 Geriatric Medicine Forecasted Market Size by Regions (2022-2027)
2.3 Geriatric Medicine Industry Dynamic
2.3.1 Geriatric Medicine Market Trends
2.3.2 Geriatric Medicine Market Drivers
2.3.3 Geriatric Medicine Market Challenges
2.3.4 Geriatric Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Geriatric Medicine Players by Revenue
3.1.1 Global Top Geriatric Medicine Players by Revenue (2016-2021)
3.1.2 Global Geriatric Medicine Revenue Market Share by Players (2016-2021)
3.2 Global Geriatric Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Geriatric Medicine Revenue
3.4 Global Geriatric Medicine Market Concentration Ratio
3.4.1 Global Geriatric Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Geriatric Medicine Revenue in 2020
3.5 Geriatric Medicine Key Players Head office and Area Served
3.6 Key Players Geriatric Medicine Product Solution and Service
3.7 Date of Enter into Geriatric Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Geriatric Medicine Breakdown Data by Type
4.1 Global Geriatric Medicine Historic Market Size by Type (2016-2021)
4.2 Global Geriatric Medicine Forecasted Market Size by Type (2022-2027)
5 Geriatric Medicine Breakdown Data by Application
5.1 Global Geriatric Medicine Historic Market Size by Application (2016-2021)
5.2 Global Geriatric Medicine Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Geriatric Medicine Market Size (2016-2027)
6.2 North America Geriatric Medicine Market Size by Type
6.2.1 North America Geriatric Medicine Market Size by Type (2016-2021)
6.2.2 North America Geriatric Medicine Market Size by Type (2022-2027)
6.2.3 North America Geriatric Medicine Market Size by Type (2016-2027)
6.3 North America Geriatric Medicine Market Size by Application
6.3.1 North America Geriatric Medicine Market Size by Application (2016-2021)
6.3.2 North America Geriatric Medicine Market Size by Application (2022-2027)
6.3.3 North America Geriatric Medicine Market Size by Application (2016-2027)
6.4 North America Geriatric Medicine Market Size by Country
6.4.1 North America Geriatric Medicine Market Size by Country (2016-2021)
6.4.2 North America Geriatric Medicine Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Geriatric Medicine Market Size (2016-2027)
7.2 Europe Geriatric Medicine Market Size by Type
7.2.1 Europe Geriatric Medicine Market Size by Type (2016-2021)
7.2.2 Europe Geriatric Medicine Market Size by Type (2022-2027)
7.2.3 Europe Geriatric Medicine Market Size by Type (2016-2027)
7.3 Europe Geriatric Medicine Market Size by Application
7.3.1 Europe Geriatric Medicine Market Size by Application (2016-2021)
7.3.2 Europe Geriatric Medicine Market Size by Application (2022-2027)
7.3.3 Europe Geriatric Medicine Market Size by Application (2016-2027)
7.4 Europe Geriatric Medicine Market Size by Country
7.4.1 Europe Geriatric Medicine Market Size by Country (2016-2021)
7.4.2 Europe Geriatric Medicine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Geriatric Medicine Market Size (2016-2027)
8.2 Asia-Pacific Geriatric Medicine Market Size by Type
8.2.1 Asia-Pacific Geriatric Medicine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Geriatric Medicine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Geriatric Medicine Market Size by Type (2016-2027)
8.3 Asia-Pacific Geriatric Medicine Market Size by Application
8.3.1 Asia-Pacific Geriatric Medicine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Geriatric Medicine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Geriatric Medicine Market Size by Application (2016-2027)
8.4 Asia-Pacific Geriatric Medicine Market Size by Region
8.4.1 Asia-Pacific Geriatric Medicine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Geriatric Medicine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Geriatric Medicine Market Size (2016-2027)
9.2 Latin America Geriatric Medicine Market Size by Type
9.2.1 Latin America Geriatric Medicine Market Size by Type (2016-2021)
9.2.2 Latin America Geriatric Medicine Market Size by Type (2022-2027)
9.2.3 Latin America Geriatric Medicine Market Size by Type (2016-2027)
9.3 Latin America Geriatric Medicine Market Size by Application
9.3.1 Latin America Geriatric Medicine Market Size by Application (2016-2021)
9.3.2 Latin America Geriatric Medicine Market Size by Application (2022-2027)
9.3.3 Latin America Geriatric Medicine Market Size by Application (2016-2027)
9.4 Latin America Geriatric Medicine Market Size by Country
9.4.1 Latin America Geriatric Medicine Market Size by Country (2016-2021)
9.4.2 Latin America Geriatric Medicine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Geriatric Medicine Market Size (2016-2027)
10.2 Middle East & Africa Geriatric Medicine Market Size by Type
10.2.1 Middle East & Africa Geriatric Medicine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Geriatric Medicine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Geriatric Medicine Market Size by Type (2016-2027)
10.3 Middle East & Africa Geriatric Medicine Market Size by Application
10.3.1 Middle East & Africa Geriatric Medicine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Geriatric Medicine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Geriatric Medicine Market Size by Application (2016-2027)
10.4 Middle East & Africa Geriatric Medicine Market Size by Country
10.4.1 Middle East & Africa Geriatric Medicine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Geriatric Medicine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Geriatric Medicine Introduction
11.1.4 GSK Revenue in Geriatric Medicine Business (2016-2021)
11.1.5 GSK Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Geriatric Medicine Introduction
11.2.4 Boehringer Ingelheim Revenue in Geriatric Medicine Business (2016-2021)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Geriatric Medicine Introduction
11.3.4 Novartis Revenue in Geriatric Medicine Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Geriatric Medicine Introduction
11.4.4 Bristol-Myers Squibb Revenue in Geriatric Medicine Business (2016-2021)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Geriatric Medicine Introduction
11.5.4 Pfizer Revenue in Geriatric Medicine Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Geriatric Medicine Introduction
11.6.4 Eli Lilly Revenue in Geriatric Medicine Business (2016-2021)
11.6.5 Eli Lilly Recent Development
11.7 Abbott
11.7.1 Abbott Company Details
11.7.2 Abbott Business Overview
11.7.3 Abbott Geriatric Medicine Introduction
11.7.4 Abbott Revenue in Geriatric Medicine Business (2016-2021)
11.7.5 Abbott Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Geriatric Medicine Introduction
11.8.4 AstraZeneca Revenue in Geriatric Medicine Business (2016-2021)
11.8.5 AstraZeneca Recent Development
11.9 Merck
11.9.1 Merck Company Details
11.9.2 Merck Business Overview
11.9.3 Merck Geriatric Medicine Introduction
11.9.4 Merck Revenue in Geriatric Medicine Business (2016-2021)
11.9.5 Merck Recent Development
11.10 Sanofi S.A.
11.10.1 Sanofi S.A. Company Details
11.10.2 Sanofi S.A. Business Overview
11.10.3 Sanofi S.A. Geriatric Medicine Introduction
11.10.4 Sanofi S.A. Revenue in Geriatric Medicine Business (2016-2021)
11.10.5 Sanofi S.A. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Geriatric Medicine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Analgesics
Table 3. Key Players of Antihypertensives
Table 4. Key Players of Statins
Table 5. Key Players of Antidiabetics
Table 6. Key Players of Proton Pump Inhibitor
Table 7. Key Players of Anticoagulant
Table 8. Key Players of Antipsychotic
Table 9. Key Players of Antidepressant
Table 10. Global Geriatric Medicine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Geriatric Medicine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Geriatric Medicine Market Size by Regions (2016-2021) & (US$ Million)
Table 13. Global Geriatric Medicine Market Share by Regions (2016-2021)
Table 14. Global Geriatric Medicine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 15. Global Geriatric Medicine Market Share by Regions (2022-2027)
Table 16. Geriatric Medicine Market Trends
Table 17. Geriatric Medicine Market Drivers
Table 18. Geriatric Medicine Market Challenges
Table 19. Geriatric Medicine Market Restraints
Table 20. Global Geriatric Medicine Revenue by Players (2016-2021) & (US$ Million)
Table 21. Global Geriatric Medicine Market Share by Players (2016-2021)
Table 22. Global Top Geriatric Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Geriatric Medicine as of 2020)
Table 23. Ranking of Global Top Geriatric Medicine Companies by Revenue (US$ Million) in 2020
Table 24. Global 5 Largest Players Market Share by Geriatric Medicine Revenue (CR5 and HHI) & (2016-2021)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Geriatric Medicine Product Solution and Service
Table 27. Date of Enter into Geriatric Medicine Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Geriatric Medicine Market Size by Type (2016-2021) (US$ Million)
Table 30. Global Geriatric Medicine Revenue Market Share by Type (2016-2021)
Table 31. Global Geriatric Medicine Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 32. Global Geriatric Medicine Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 33. Global Geriatric Medicine Market Size Share by Application (2016-2021) & (US$ Million)
Table 34. Global Geriatric Medicine Revenue Market Share by Application (2016-2021)
Table 35. Global Geriatric Medicine Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 36. Global Geriatric Medicine Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 37. North America Geriatric Medicine Market Size by Type (2016-2021) (US$ Million)
Table 38. North America Geriatric Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 39. North America Geriatric Medicine Market Size by Application (2016-2021) (US$ Million)
Table 40. North America Geriatric Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 41. North America Geriatric Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 42. North America Geriatric Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 43. Europe Geriatric Medicine Market Size by Type (2016-2021) (US$ Million)
Table 44. Europe Geriatric Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 45. Europe Geriatric Medicine Market Size by Application (2016-2021) (US$ Million)
Table 46. Europe Geriatric Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 47. Europe Geriatric Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 48. Europe Geriatric Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Geriatric Medicine Market Size by Type (2016-2021) (US$ Million)
Table 50. Asia-Pacific Geriatric Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Geriatric Medicine Market Size by Application (2016-2021) (US$ Million)
Table 52. Asia-Pacific Geriatric Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Geriatric Medicine Market Size by Region (2016-2021) & (US$ Million)
Table 54. Asia-Pacific Geriatric Medicine Market Size by Region (2022-2027) & (US$ Million)
Table 55. Latin America Geriatric Medicine Market Size by Type (2016-2021) (US$ Million)
Table 56. Latin America Geriatric Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 57. Latin America Geriatric Medicine Market Size by Application (2016-2021) (US$ Million)
Table 58. Latin America Geriatric Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 59. Latin America Geriatric Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 60. Latin America Geriatric Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Geriatric Medicine Market Size by Type (2016-2021) (US$ Million)
Table 62. Middle East & Africa Geriatric Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Geriatric Medicine Market Size by Application (2016-2021) (US$ Million)
Table 64. Middle East & Africa Geriatric Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Geriatric Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 66. Middle East & Africa Geriatric Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 67. GSK Company Details
Table 68. GSK Business Overview
Table 69. GSK Geriatric Medicine Product
Table 70. GSK Revenue in Geriatric Medicine Business (2016-2021) & (US$ Million)
Table 71. GSK Recent Development
Table 72. Boehringer Ingelheim Company Details
Table 73. Boehringer Ingelheim Business Overview
Table 74. Boehringer Ingelheim Geriatric Medicine Product
Table 75. Boehringer Ingelheim Revenue in Geriatric Medicine Business (2016-2021) & (US$ Million)
Table 76. Boehringer Ingelheim Recent Development
Table 77. Novartis Company Details
Table 78. Novartis Business Overview
Table 79. Novartis Geriatric Medicine Product
Table 80. Novartis Revenue in Geriatric Medicine Business (2016-2021) & (US$ Million)
Table 81. Novartis Recent Development
Table 82. Bristol-Myers Squibb Company Details
Table 83. Bristol-Myers Squibb Business Overview
Table 84. Bristol-Myers Squibb Geriatric Medicine Product
Table 85. Bristol-Myers Squibb Revenue in Geriatric Medicine Business (2016-2021) & (US$ Million)
Table 86. Bristol-Myers Squibb Recent Development
Table 87. Pfizer Company Details
Table 88. Pfizer Business Overview
Table 89. Pfizer Geriatric Medicine Product
Table 90. Pfizer Revenue in Geriatric Medicine Business (2016-2021) & (US$ Million)
Table 91. Pfizer Recent Development
Table 92. Eli Lilly Company Details
Table 93. Eli Lilly Business Overview
Table 94. Eli Lilly Geriatric Medicine Product
Table 95. Eli Lilly Revenue in Geriatric Medicine Business (2016-2021) & (US$ Million)
Table 96. Eli Lilly Recent Development
Table 97. Abbott Company Details
Table 98. Abbott Business Overview
Table 99. Abbott Geriatric Medicine Product
Table 100. Abbott Revenue in Geriatric Medicine Business (2016-2021) & (US$ Million)
Table 101. Abbott Recent Development
Table 102. AstraZeneca Company Details
Table 103. AstraZeneca Business Overview
Table 104. AstraZeneca Revenue in Geriatric Medicine Business (2016-2021) & (US$ Million)
Table 105. AstraZeneca Recent Development
Table 106. Merck Company Details
Table 107. Merck Business Overview
Table 108. Merck Geriatric Medicine Product
Table 109. Merck Revenue in Geriatric Medicine Business (2016-2021) & (US$ Million)
Table 110. Merck Recent Development
Table 111. Sanofi S.A. Company Details
Table 112. Sanofi S.A. Business Overview
Table 113. Sanofi S.A. Geriatric Medicine Product
Table 114. Sanofi S.A. Revenue in Geriatric Medicine Business (2016-2021) & (US$ Million)
Table 115. Sanofi S.A. Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Geriatric Medicine Market Share by Type: 2020 VS 2027
Figure 2. Analgesics Features
Figure 3. Antihypertensives Features
Figure 4. Statins Features
Figure 5. Antidiabetics Features
Figure 6. Proton Pump Inhibitor Features
Figure 7. Anticoagulant Features
Figure 8. Antipsychotic Features
Figure 9. Antidepressant Features
Figure 10. Global Geriatric Medicine Market Share by Application: 2020 VS 2027
Figure 11. Cardiovascular Case Studies
Figure 12. Arthritis Case Studies
Figure 13. Neurological Case Studies
Figure 14. Cancer Case Studies
Figure 15. Osteoporosis Case Studies
Figure 16. Respiratory Case Studies
Figure 17. Geriatric Medicine Report Years Considered
Figure 18. Global Geriatric Medicine Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 19. Global Geriatric Medicine Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 20. Global Geriatric Medicine Market Share by Regions: 2020 VS 2027
Figure 21. Global Geriatric Medicine Market Share by Regions (2022-2027)
Figure 22. Global Geriatric Medicine Market Share by Players in 2020
Figure 23. Global Top Geriatric Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Geriatric Medicine as of 2020
Figure 24. The Top 10 and 5 Players Market Share by Geriatric Medicine Revenue in 2020
Figure 25. Global Geriatric Medicine Revenue Market Share by Type (2016-2021)
Figure 26. Global Geriatric Medicine Revenue Market Share by Type (2022-2027)
Figure 27. North America Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. North America Geriatric Medicine Market Share by Type (2016-2027)
Figure 29. North America Geriatric Medicine Market Share by Application (2016-2027)
Figure 30. North America Geriatric Medicine Market Share by Country (2016-2027)
Figure 31. United States Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Canada Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Europe Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Europe Geriatric Medicine Market Share by Type (2016-2027)
Figure 35. Europe Geriatric Medicine Market Share by Application (2016-2027)
Figure 36. Europe Geriatric Medicine Market Share by Country (2016-2027)
Figure 37. Germany Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. France Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. U.K. Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Italy Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Russia Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Nordic Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Asia-Pacific Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Asia-Pacific Geriatric Medicine Market Share by Type (2016-2027)
Figure 45. Asia-Pacific Geriatric Medicine Market Share by Application (2016-2027)
Figure 46. Asia-Pacific Geriatric Medicine Market Share by Region (2016-2027)
Figure 47. China Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Japan Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. South Korea Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Southeast Asia Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. India Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Australia Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Latin America Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Latin America Geriatric Medicine Market Share by Type (2016-2027)
Figure 55. Latin America Geriatric Medicine Market Share by Application (2016-2027)
Figure 56. Latin America Geriatric Medicine Market Share by Country (2016-2027)
Figure 57. Mexico Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Brazil Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Middle East & Africa Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Middle East & Africa Geriatric Medicine Market Share by Type (2016-2027)
Figure 61. Middle East & Africa Geriatric Medicine Market Share by Application (2016-2027)
Figure 62. Middle East & Africa Geriatric Medicine Market Share by Country (2016-2027)
Figure 63. Turkey Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Saudi Arabia Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 65. UAE Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 66. GSK Revenue Growth Rate in Geriatric Medicine Business (2016-2021)
Figure 67. Boehringer Ingelheim Revenue Growth Rate in Geriatric Medicine Business (2016-2021)
Figure 68. Novartis Revenue Growth Rate in Geriatric Medicine Business (2016-2021)
Figure 69. Bristol-Myers Squibb Revenue Growth Rate in Geriatric Medicine Business (2016-2021)
Figure 70. Pfizer Revenue Growth Rate in Geriatric Medicine Business (2016-2021)
Figure 71. Eli Lilly Revenue Growth Rate in Geriatric Medicine Business (2016-2021)
Figure 72. Abbott Revenue Growth Rate in Geriatric Medicine Business (2016-2021)
Figure 73. AstraZeneca Revenue Growth Rate in Geriatric Medicine Business (2016-2021)
Figure 74. Merck Revenue Growth Rate in Geriatric Medicine Business (2016-2021)
Figure 75. Sanofi S.A. Revenue Growth Rate in Geriatric Medicine Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs